Concepedia

Jean-Marc A. Nabholtz

JA

Statistics

Publications

2

Citations

62

H-Index

2

Active since

2002

Affiliations

King Saud University(Current)

Jean-Marc A. Nabholtz is an author at King Saud University specializing in cancer therapeutics, clinical trials, and radiation oncology.

Top concepts

Publications per year

2002–2020

2

Publications

2

Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Jean-Marc A. Nabholtz, Jacques Cantin, José Chang et al. · Clinical Breast Cancer · 2002 · 51 citations

, , +9

Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial.

Khalid Alsaleh, A. Bounedjar, Mohammed Oukkal et al. · Journal of Clinical Oncology · 2020 · 11 citations

, , +20

1–2 of 2